SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001140361-24-028580
Filing Date
2024-06-03
Accepted
2024-06-03 16:41:17
Documents
6

Document Format Files

Seq Description Document Type Size
1 ny20025434x3_s3a.htm S-3/A 258120
2 EXHIBIT 5.1 ny20025434x3_ex5-1.htm EX-5.1 13837
3 EXHIBIT 23.1 ny20025434x3_ex23-1.htm EX-23.1 1993
4 FILING FEES TABLE ny20025434x3_ex107.htm EX-FILING FEES 20265
5 logo_eliciox1.jpg GRAPHIC 33082
6 logo_mintz.jpg GRAPHIC 2596
  Complete submission text file 0001140361-24-028580.txt   344415
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-278373 | Film No.: 241014335
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)